Cargando…

Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients

Detalles Bibliográficos
Autores principales: Lyski, Zoe L., Kim, Sunny, Lee, David Xthona, Sampson, David, Raué, Hans P., Raghunathan, Vikram, Ryan, Debbie, Brunton, Amanda E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/
https://www.ncbi.nlm.nih.gov/pubmed/34518841
http://dx.doi.org/10.1101/2021.09.02.21262146
_version_ 1783752148558807040
author Lyski, Zoe L.
Kim, Sunny
Lee, David Xthona
Sampson, David
Raué, Hans P.
Raghunathan, Vikram
Ryan, Debbie
Brunton, Amanda E.
Slifka, Mark K.
Messer, William B.
Spurgeon, Stephen E.
author_facet Lyski, Zoe L.
Kim, Sunny
Lee, David Xthona
Sampson, David
Raué, Hans P.
Raghunathan, Vikram
Ryan, Debbie
Brunton, Amanda E.
Slifka, Mark K.
Messer, William B.
Spurgeon, Stephen E.
author_sort Lyski, Zoe L.
collection PubMed
description
format Online
Article
Text
id pubmed-8437317
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-84373172021-09-14 Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients Lyski, Zoe L. Kim, Sunny Lee, David Xthona Sampson, David Raué, Hans P. Raghunathan, Vikram Ryan, Debbie Brunton, Amanda E. Slifka, Mark K. Messer, William B. Spurgeon, Stephen E. medRxiv Article Cold Spring Harbor Laboratory 2021-09-07 /pmc/articles/PMC8437317/ /pubmed/34518841 http://dx.doi.org/10.1101/2021.09.02.21262146 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Lyski, Zoe L.
Kim, Sunny
Lee, David Xthona
Sampson, David
Raué, Hans P.
Raghunathan, Vikram
Ryan, Debbie
Brunton, Amanda E.
Slifka, Mark K.
Messer, William B.
Spurgeon, Stephen E.
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title_full Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title_fullStr Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title_full_unstemmed Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title_short Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
title_sort immunogenicity of pfizer mrna covid-19 vaccination followed by j&j adenovirus covid-19 vaccination in two cll patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/
https://www.ncbi.nlm.nih.gov/pubmed/34518841
http://dx.doi.org/10.1101/2021.09.02.21262146
work_keys_str_mv AT lyskizoel immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT kimsunny immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT leedavidxthona immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT sampsondavid immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT rauehansp immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT raghunathanvikram immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT ryandebbie immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT bruntonamandae immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT slifkamarkk immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT messerwilliamb immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients
AT spurgeonstephene immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients